Red blood cell distribution width as a prognostic biomarker for viral infections: Prospects and challenges

Oloche Owoicho, Kesego Tapela, Charles O. Olwal, Alexandra L. Djomkam Zune, Nora N. Nganyewo, Osbourne Quaye

Research output: Contribution to journalReview articlepeer-review

17 Citations (Scopus)

Abstract

Viral diseases remain a significant global health threat, and therefore prioritization of limited healthcare resources is required to effectively manage dangerous viral disease outbreaks. In a pandemic of a newly emerged virus that is yet to be well understood, a noninvasive host-derived prognostic biomarker is invaluable for risk prediction. Red blood cell distribution width (RDW), an index of red blood cell size disorder (anisocytosis), is a potential predictive biomarker for severity of many diseases. In view of the need to prioritize resources during response to outbreaks, this review highlights the prospects and challenges of RDW as a prognostic biomarker for viral infections, with a focus on hepatitis and COVID-19, and provides an outlook to improve the prognostic performance of RDW for risk prediction in viral diseases.

Original languageEnglish
Pages (from-to)41-50
Number of pages10
JournalBiomarkers in Medicine
Volume16
Issue number1
DOIs
Publication statusPublished - Jan 2022

Keywords

  • anisocytosis
  • prognostic biomarkers
  • red blood cell distribution width
  • red blood cells

Fingerprint

Dive into the research topics of 'Red blood cell distribution width as a prognostic biomarker for viral infections: Prospects and challenges'. Together they form a unique fingerprint.

Cite this